Literature DB >> 26622884

Primary neuroendocrine tumors of the ear, nose and throat: A report of three cases and a review of the literature.

Rachad Mhawej1, Chadi Farah1, Amine Haddad1, Bassam Tabchy1.   

Abstract

The aim of the present study was to review all cases of neuroendocrine tumors of the ear, nose and throat in a tertiary care center, as well as the data published in the literature. The study presents all the cases of neuroendocrine tumors (NETs) in the Hotel Dieu De France Hospital (Beirut, Lebanon) between January 2004 and January 2014. The data reported in the English and French literature is also reviewed with regard to the typical clinical presentation and management of these tumors. Three cases of NETs presented to the Department of Otolaryngology-Head and Neck Surgery during the study period. One case was of an atypical carcinoid (AC) tumor of the larynx, one case was of a typical carcinoid tumor in the middle ear and the third case was, to the best of our knowledge, the first reported case of an AC tumor of the nasopharynx. Overall, NETs are rare in the head and neck. The clinical presentation can mimic any other tumor in the same localization in the absence of a carcinoid syndrome. Management of these tumors remains controversial, but a complete excision of the tumor is crucial, followed by possible adjuvant treatment.

Entities:  

Keywords:  head and neck; larynx; middle ear; nasopharynx; neuroendocrine tumors

Year:  2015        PMID: 26622884      PMCID: PMC4580071          DOI: 10.3892/ol.2015.3606

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  24 in total

Review 1.  The spectrum of endocrinocarcinomas of the larynx.

Authors:  Alfio Ferlito; Alessandra Rinaldo
Journal:  Oral Oncol       Date:  2005-04-14       Impact factor: 5.337

2.  Carcinoid tumours of the middle ear.

Authors:  Keiji Tabuchi; Yasunori Aoyagi; Isao Uemaetomari; Tadamichi Tobita; Tetsuro Wada; Yukinori Inadome; Masayuki Noguchi; Akira Hara
Journal:  J Otolaryngol Head Neck Surg       Date:  2009-06

Review 3.  Neuroendocrine neoplasms of the larynx: advances in identification, understanding, and management.

Authors:  Alfio Ferlito; Kenneth O Devaney; Alessandra Rinaldo
Journal:  Oral Oncol       Date:  2006-07-11       Impact factor: 5.337

4.  Neuroendocrine carcinoma of the head and neck: a 20-year case series.

Authors:  Ryan Meacham; Laura Matrka; Enver Ozer; H Gulcin Ozer; Paul Wakely; Manisha Shah
Journal:  Ear Nose Throat J       Date:  2012-03       Impact factor: 1.697

5.  Primary carcinoid tumor of the frontal sinus: A case report.

Authors:  Michael W Chu; Daniel W Karakla; Marc Silverberg; Joseph K Han
Journal:  Ear Nose Throat J       Date:  2010-10       Impact factor: 1.697

Review 6.  Laryngeal paraganglioma: an updated critical review.

Authors:  David Myssiorek; Alessandra Rinaldo; Leon Barnes; Alfio Ferlito
Journal:  Acta Otolaryngol       Date:  2004-11       Impact factor: 1.494

Review 7.  Carcinoid and neuroendocrine tumors: building on success.

Authors:  Pamela L Kunz
Journal:  J Clin Oncol       Date:  2015-04-27       Impact factor: 44.544

Review 8.  Primary carcinoid tumour of nasal septum.

Authors:  T Galm; N Turner
Journal:  J Laryngol Otol       Date:  2008-09-02       Impact factor: 1.469

Review 9.  Clinical recommendations on the treatment of neuroendocrine carcinoma of the larynx: A meta-analysis of 436 reported cases.

Authors:  Tom P van der Laan; Boudewijn E C Plaat; Bernard F A M van der Laan; Gyorgy B Halmos
Journal:  Head Neck       Date:  2014-06-18       Impact factor: 3.147

10.  Carcinoid tumours of the larynx.

Authors:  Urmi Bapat; Neil A Mackinnon; Michael G Spencer
Journal:  Eur Arch Otorhinolaryngol       Date:  2004-05-25       Impact factor: 2.503

View more
  1 in total

1.  Diagnosis and treatment of a rare sinonasal neuroendocrine tumour: adding to the evidence.

Authors:  Aashrai Gudlavalleti; Ryan Dean; Yuxin Liu; Amit S Dhamoon
Journal:  BMJ Case Rep       Date:  2016-09-13
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.